Prostate Cancer Clinical Trials in Richmond, Virginia

4 studies are recruiting for prostate cancer in Richmond, Virginia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

   This study is being done to answer the following question: Is the strategy to give higher doses of radiotherapy treatment over a shorter period of time using special equipment and fewer treatments (also known as Stereotactic Body Radiation Therapy or SBRT) as effective as usual external radiation t…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Bon Secours Cancer Institute at Reynolds Crossing, Richmond, Virginia

   Locations

   57 in total

   Run by

   Canadian Cancer Trials Group

   See if you can join NCT06235697 on ClinicalTrials.gov

2. Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

   This is a prospective, open-label, multi-center seamless phase II to phase III randomized clinical trial designed to compare SST with or without PET-directed local therapy in improving the castration-resistant prostate cancer-free survival (CRPC-free survival) for Veterans with oligometastatic pros…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond, Virginia

   Locations

   20 in total

   Run by

   VA Office of Research and Development

   See if you can join NCT04787744 on ClinicalTrials.gov

3. Stratagen Quantitative Prostate MRI Platform Pilot Study

   The goal of this clinical trial is to assess the safety and feasibility of the Stratagen Quantitative Prostate MRI Platform when used in addition to the standard scans conducted during the existing prostate MRI sessions. * What severe problems, if any, occur because of the use of the Stratagen Quan…

   Stage

   Not phased

   Ages

   40 to 90

   Site

   Virginia Urology, Richmond, Virginia

   Locations

   2 in total

   Run by

   Stratagen Bio, Inc.

   See if you can join NCT06985238 on ClinicalTrials.gov

4. Behavioral Exercise Training to Reduce Cardiovascular Disease Risk

   To test the preliminary effectiveness of a home-based exercise training (ET) intervention to improve exercise capacity (VO2 peak \& 6-minute walk distance [6MWD]) among prostate cancer (PC) patients compared to controls receiving healthy living education (HLE) at 12 weeks.

   Stage

   Phase 1

   Ages

   40 to 85

   Site

   Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia

   Locations

   2 in total

   Run by

   Virginia Commonwealth University

   See if you can join NCT06237179 on ClinicalTrials.gov